KVUE * Stock Overview
Operates as a consumer health company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Kenvue Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$439.23 |
| 52 Week High | US$439.23 |
| 52 Week Low | US$316.81 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 17.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| KVUE * | MX Personal Products | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how KVUE * performed against the MX Personal Products industry.
Return vs Market: Insufficient data to determine how KVUE * performed against the MX Market.
Price Volatility
| KVUE * volatility | |
|---|---|
| KVUE * Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: KVUE *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine KVUE *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 22,000 | Thibaut Mongon | www.kenvue.com |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Kenvue Inc. Fundamentals Summary
| KVUE * fundamental statistics | |
|---|---|
| Market cap | Mex$823.48b |
| Earnings (TTM) | Mex$21.97b |
| Revenue (TTM) | Mex$319.22b |
37.5x
P/E Ratio2.6x
P/S RatioIs KVUE * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KVUE * income statement (TTM) | |
|---|---|
| Revenue | US$15.46b |
| Cost of Revenue | US$6.51b |
| Gross Profit | US$8.95b |
| Other Expenses | US$7.89b |
| Earnings | US$1.06b |
Last Reported Earnings
Sep 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.55 |
| Gross Margin | 57.90% |
| Net Profit Margin | 6.88% |
| Debt/Equity Ratio | 80.7% |
How did KVUE * perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield145%
Payout RatioDoes KVUE * pay a reliable dividends?
See KVUE * dividend history and benchmarks| Kenvue dividend dates | |
|---|---|
| Ex Dividend Date | Feb 12 2025 |
| Dividend Pay Date | Feb 26 2025 |
| Days until Ex dividend | 19 days |
| Days until Dividend pay date | 33 days |
Does KVUE * pay a reliable dividends?
See KVUE * dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/22 10:50 |
| End of Day Share Price | 2025/01/14 00:00 |
| Earnings | 2024/09/29 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kenvue Inc. is covered by 21 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Lauren Lieberman | Barclays |
| Navann Ty Dietschi | BNP Paribas Exane |